These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

713 related items for PubMed ID: 17721372

  • 1. Concomitant administration of a virosome-adjuvanted hepatitis a vaccine with routine childhood vaccines at age twelve to fifteen months: a randomized controlled trial.
    Dagan R, Amir J, Livni G, Greenberg D, Abu-Abed J, Guy L, Ashkenazi S, Foresner G, Tewald F, Schätzl HM, Hoffmann D, Ibanez R, Herzog C.
    Pediatr Infect Dis J; 2007 Sep; 26(9):787-93. PubMed ID: 17721372
    [Abstract] [Full Text] [Related]

  • 2. Immunogenicity and safety of a pediatric dose of a virosome-adjuvanted hepatitis A vaccine: a controlled trial in children aged 1-16 years.
    Van Der Wielen M, Vertruyen A, Froesner G, Ibáñez R, Hunt M, Herzog C, Van Damme P.
    Pediatr Infect Dis J; 2007 Aug; 26(8):705-10. PubMed ID: 17848882
    [Abstract] [Full Text] [Related]

  • 3. Safety, tolerability and immunogenicity of VAQTA given concomitantly versus nonconcomitantly with other pediatric vaccines in healthy 12-month-old children.
    Guerra FA, Gress J, Werzberger A, Reisinger K, Walter E, Lakkis H, Grosso AD, Welebob C, Kuter BJ, Pediatric Study Group for VAQTA.
    Pediatr Infect Dis J; 2006 Oct; 25(10):912-9. PubMed ID: 17006287
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity and tolerability of a paediatric presentation of a virosomal hepatitis A vaccine in Chilean children aged 1-16 years.
    Abarca K, Ibáñez I, de la Fuente P, Cerda L, Bergeret J, Frösner G, Ibarra H.
    Vaccine; 2011 Nov 08; 29(48):8855-62. PubMed ID: 21983354
    [Abstract] [Full Text] [Related]

  • 5. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
    Abarca K, Ibánez I, Perret C, Vial P, Zinsou JA.
    Int J Infect Dis; 2008 May 08; 12(3):270-7. PubMed ID: 17988917
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.
    Nolan T, Bernstein H, Blatter MM, Bromberg K, Guerra F, Kennedy W, Pichichero M, Senders SD, Trofa A, Collard A, Sullivan DC, Descamps D.
    Pediatrics; 2006 Sep 08; 118(3):e602-9. PubMed ID: 16950952
    [Abstract] [Full Text] [Related]

  • 7. Rapid antibody response after vaccination with a virosomal hepatitis a vaccine.
    Ambrosch F, Finkel B, Herzog C, Koren A, Kollaritsch H.
    Infection; 2004 Jun 08; 32(3):149-52. PubMed ID: 15188074
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly.
    D'Acremont V, Herzog C, Genton B.
    J Travel Med; 2006 Jun 08; 13(2):78-83. PubMed ID: 16553593
    [Abstract] [Full Text] [Related]

  • 9. Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with Diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines in children 15 months of age.
    Trofa AF, Klein NP, Paul IM, Michaels MG, Goessler M, Chandrasekaran V, Blatter M.
    Pediatr Infect Dis J; 2011 Sep 08; 30(9):e164-9. PubMed ID: 21494175
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunogenicity and safety of a pediatric dose of a virosomal hepatitis A vaccine in healthy children in India.
    Jain H, Kumavat V, Singh T, Versteilen A, Sarnecki M.
    Hum Vaccin Immunother; 2014 Sep 08; 10(7):2089-97. PubMed ID: 25424821
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of age.
    Blatter MM, Klein NP, Shepard JS, Leonardi M, Shapiro S, Schear M, Mufson MA, Martin JM, Varman M, Grogg S, London A, Cambron P, Douha M, Nicholson O, da Costa C, Innis BL.
    Pediatr Infect Dis J; 2012 Aug 08; 31(8):e133-40. PubMed ID: 22622699
    [Abstract] [Full Text] [Related]

  • 13. Virosomal hepatitis a vaccine: comparing intradermal and subcutaneous with intramuscular administration.
    Frösner G, Steffen R, Herzog C.
    J Travel Med; 2009 Aug 08; 16(6):413-9. PubMed ID: 19930383
    [Abstract] [Full Text] [Related]

  • 14. Immunogenicity and safety of a virosomal hepatitis A vaccine in HIV-positive patients.
    Loutan L, Bovier P, Herzog C.
    Vaccine; 2007 Aug 21; 25(34):6310-2. PubMed ID: 17640777
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity and safety of a pediatric dose virosomal hepatitis A vaccine in Thai HIV-infected children.
    Saksawad R, Likitnukul S, Warachit B, Hanvivatvong O, Poovorawan Y, Puripokai P.
    Vaccine; 2011 Jun 24; 29(29-30):4735-8. PubMed ID: 21570433
    [Abstract] [Full Text] [Related]

  • 16. Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with measles-mumps-rubella and varicella vaccines in children less than 2 years of age.
    Rinderknecht S, Michaels MG, Blatter M, Gaglani M, Andrews W, Abughali N, Chandreshekaran V, Trofa AF.
    Pediatr Infect Dis J; 2011 Oct 24; 30(10):e179-85. PubMed ID: 21617573
    [Abstract] [Full Text] [Related]

  • 17. Epaxal: a virosomal vaccine to prevent hepatitis A infection.
    Bovier PA.
    Expert Rev Vaccines; 2008 Oct 24; 7(8):1141-50. PubMed ID: 18844588
    [Abstract] [Full Text] [Related]

  • 18. Interchangeability and tolerability of a virosomal and an aluminum-adsorbed hepatitis A vaccine.
    Bovier PA, Farinelli T, Loutan L.
    Vaccine; 2005 Mar 31; 23(19):2424-9. PubMed ID: 15752828
    [Abstract] [Full Text] [Related]

  • 19. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.
    Tejedor JC, Moro M, Ruiz-Contreras J, Castro J, Gómez-Campderá JA, Navarro ML, Merino JM, Martín-Ancel A, Roca J, García-del-Río M, Jurado A, Díez-Delgado FJ, Omeñaca F, García-Sicilia J, Boceta R, García-Corbeira P, Jacquet JM, Collard A, Schuerman L, Spanish DTaP-HBV-IPV-097 Study Group.
    Pediatr Infect Dis J; 2006 Aug 31; 25(8):713-20. PubMed ID: 16874171
    [Abstract] [Full Text] [Related]

  • 20. Immunogenicity of booster vaccination with a virosomal hepatitis A vaccine after primary immunization with an aluminum-adsorbed hepatitis A vaccine.
    Beck BR, Hatz CF, Loutan L, Steffen R.
    J Travel Med; 2004 Aug 31; 11(4):201-6. PubMed ID: 15541221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.